Pyrimidine nucleoside metabolic process

pathway activity — cross-omics
GO:0006213Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyrimidine nucleoside metabolic process pathway is significantly associated with the protein abundance of multiple proteins, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are PML, UPP1, and CASP1, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine nucleoside metabolic process activity versus PML in LSCC (Pearson r = 0.17).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCPML →+0.422+0.045<.001.00237
LSCCUPP1 →+0.448+0.036<.001.00437
BRCACASP1 →+0.358+0.025<.001<.00137
OVIFI35 →+0.506+0.049<.001<.00137
GBMGBP2 →+0.449+0.029.003.00136
BRCASERPINB9 →+0.546+0.039<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0006213 vs PML — LSCC

Per-sample scatter of Pyrimidine nucleoside metabolic process activity vs PML in LSCC.

Explore this scatter interactively →

Exploration